Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Barr Pharmaceuticals, Inc.
Report 1: Barr Pharmaceuticals, Inc. (NYSE:BRL) announced that its subsidiary, Barr Laboratories, Inc. ("Barr"), and Eli Lilly & Company ("Lilly") voluntarily stipulated that all claims asserted by Lilly against Barr and all counterclaims asserted by Barr against Lilly in the patent litigation between the two parties related to Lilly's Prozac(R) Weekly(TM) (Fluoxetine Hydrochloride) Capsules, USP 90 mg have been dismissed. The patent litigation had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.